The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.
Study Type
OBSERVATIONAL
Enrollment
300
Duke Cancer Center
Durham, North Carolina, United States
RECRUITINGNumber of circulating immune cells in peripheral blood
reported as mean +/- standard deviation
Time frame: 6 weeks post radiation therapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.